UniProt Q9NWM8
Q9NWM8
Q9NWM8 (UniProt Q9NWM8): 4 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- Q9NWM8
- Experimental structures
- 4
- Predicted models
- 1
Structures
5 records of Q9NWM8 in the MolNFT archive: 4 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 4DIP | Crystal structure of human Peptidyl-prolyl cis-trans isomerase FKBP14 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J | — | — |
| 4DIP | Crystal structure of human peptidyl-prolyl cis-trans isomerase FKBP14 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J | — | — |
| 4MSP | Crystal structure of human peptidyl-prolyl cis-trans isomerase FKBP22 (aka FKBP14) containing two… | x-ray diffraction | A, B | — | — |
| 4MSP | Crystal structure of human peptidyl-prolyl cis-trans isomerase FKBP22 (aka FKBP14) containing two… | x-ray diffraction | A, B | — | — |
| Q9NWM8 | AlphaFold monomer V2.0 prediction for peptidyl-prolyl cis-trans isomerase FKBP14 (Q9NWM8) | predicted | A | — | — |
Experiment against prediction
- 4DIP chain E against the predicted model Q9NWM8: TM-score 0.98, RMSD 0.76 Å
- 4DIP chain E against the predicted model Q9NWM8: TM-score 0.98, RMSD 0.76 Å
- 4DIP chain C against the predicted model Q9NWM8: TM-score 0.97, RMSD 0.85 Å
- 4DIP chain C against the predicted model Q9NWM8: TM-score 0.97, RMSD 0.85 Å
- 4DIP chain A against the predicted model Q9NWM8: TM-score 0.97, RMSD 0.90 Å
- 4DIP chain A against the predicted model Q9NWM8: TM-score 0.97, RMSD 0.90 Å
- 4DIP chain G against the predicted model Q9NWM8: TM-score 0.97, RMSD 0.94 Å
- 4DIP chain G against the predicted model Q9NWM8: TM-score 0.97, RMSD 0.94 Å
- 4DIP chain B against the predicted model Q9NWM8: TM-score 0.97, RMSD 1.07 Å
- 4DIP chain B against the predicted model Q9NWM8: TM-score 0.97, RMSD 1.07 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.